Endocrinology, Diabetes and MetabolismÌýResearch
RESEARCH SUMMARY
Our group also conducts clinical/translational research at outpatient clinics and inpatient service sites within the University of Toledo Health Science Campus (University of Toledo Medical Center, Ruppert Health Center, Dana Cancer Center) and the ProMedica Health Campus (The Toledo Hospital and the Falzone Diabetes Center).Ìý Basic sciences research is conducted at the Center for Diabetes and Endocrine Research (CeDER) at the ÍÃ×ÓÏÈÉú´«Ã½ÎÄ»¯×÷Æ· Health Science Campus.Ìý
Scientifically, the Division’s research encompasses clinical, translational and basic science areas as described below:
Current Clinical/Translational projects include:
- Latent Autoimmune Diabetes of Adult Database Study (IRB approved)
- Anti-Program Cell Death-1 Pathway Blockade and Type 1 Diabetes Development (MEDTRONIC GRANT AWARD)Ìý(IRB approved)
- Calcitonin Enhanced Localization of Parathyroid AdenomasÌý(IRB approved)
- Thyroid Nodule Database StudyÌý(IRB approved)
- Insulin Antibodies and Insulin ResistanceÌý(IRB approved)
- Glycemic Control with Digitally Coordinated Care in Type II Diabetic Populations (IRB approved)
- Low Dose CT and Adrenal IncidentalomasÌý(IRB approved)
- ³§³Ò³¢°Õ2ÌýProtracted Glycosuria (IRB pending)
- New Onset Diabetes After Transplant (NODAT, IRB pending)
- Glycemic variability during enteral nutrition (IRB pending)
- Inpatient Steroids and Diabetes Best Practice Alert (IRB pending)
- SDOH in Diabetes: Continuous Glucose Monitor Systems in underserved populations (QIP)
Current Basic/Translational projects include:
- Characterization of a New Humanized Transgenic Model of Type 1 DiabetesÌý(US Patent filed)
- Immunotherapeutic Treatments of Allo and AutoimmunityÌýÌý(International Patent filed-Business Incubator: AdopTracell®)
- Thyroid Cancer Cellular BiomarkersÌý(US Patent filed)
- Tumor Immunity Induction Studies
For details on Division’s basic sciences research program go to:
LabS WebsiteS
JOHN JUN LAB
Shahnawaz Imam LAB
Recent /relevant peer reviewed abstracts/papers (2015 to present)
- J. B. Hao, A. Schuna and J. C. Jaume. Extree Insulin Resistance from Insulin Antibodies (not Insulin Receptor Antibodies) Successfully Treated with Combination Immunosuppresive Therapy.Ìý The Endocrine Society.Ìý San Diego, CA 2015.
- S. Imam, R. Paparodis and J. C. Jaume.Ìý Does Macrophage Plasticity in Thyroid Microenvironment Decide the Fate of Thyroid cancer?Ìý The Endocrine Society.Ìý San Diego, CA 2015.
- R. Paparodis R and J. C. Jaume.Ìý Reanalysis of the data reveal even stronger associations between Hashimoto's thyroiditis and differentiated thyroid cancer.Ìý Thyroid. 2015;25:142
- J. B. Hao, S Thida, S Sirinvaravong, A Day and J. C. Jaume*.Ìý Early Adulthood Onset Diabetes: T1DM, T2DM, Latent Autoimmune Diabetes of Adults, does it really matter?Ìý The Endocrine Society.Ìý Boston, MA 2016.Ìý *Helmsley Charitable Abstract Award in T1D
- A. Renno, J.B. Hao, S. Imam, J.C. Jaume.Ìý An FDA Approve Drug that Causes Type 1 Diabetes.Ìý Is it Just Coincidence?Ìý The Endocrine Society.Ìý Boston, MA 2016.
- J. B. Hao, A. Renno, S. Imam, M. A. Alfonso-Jaume, N. Elnagar and J. C. Jaume.Ìý Development of Type 1 Diabetes after Cancer Immunotherapy. ÌýEndocr Pract Epub 2016.
- J. B. Hao, S. Imam, P. Dar, M. A. Alfonso-Jaume, N. Elnagar and J. C. Jaume. ÌýExtreme
Insulin Resistance from Insulin Antibodies (Not Insulin Receptor Antibodies) Succesfully
Treated with Combination Immunosuppressive Therapy.ÌýDiabetes Care Epub 2016.
- R.D. Paparodis, D. Bantouna, S. Imam and J.C. Jaume.ÌýThe Risk of Thyroid Cancer Depends on the Type of Autoimmune Thyroid Disease Associated with It.ÌýÌýThe Endocrine Society.ÌýÌýOrlando, FL 2017.
- G. Antoniou, S. Kasikis, C. Chourpiliadis, D. Bantouna, J.C. Jaume and R.D. Paparodis.ÌýÌýPatients with History of Fractures Have Profound Abnormalities in Bone Metabolism and Thyroid Function.ÌýÌýThe Endocrine Society.ÌýÌýOrlando, FL 2017.
- R.D. Paparodis, D. Bantouna, S. Imam and J.C. Jaume.ÌýHigher Serum TSH Is Associated with Differentiated Thyroid Cancer Risk, Only in the Absence of Thyroid Autoimmunity.ÌýThe Endocrine Society.ÌýÌýOrlando, FL 2017.
- S. Imam, P Dar, K. Almotah, R.D. Paparodis and J.C. Jaume.ÌýÌýMacrophage-Natural Killer Cell Cross-Talk: Implications for Thyroid Cancer.ÌýÌýThe Endocrine Society.ÌýÌýOrlando, FL 2017.
- R.D. Paparodis, D. Bantouna, S. Imam and J.C. Jaume.ÌýComparison of Features of Tumor Aggressiveness Between Thyroid Papillary Microcarcinomas and Macrocarcinomas.ÌýÌýThe Endocrine Society.ÌýÌýOrlando, FL 2017.
- G. Antoniou, S. Kasikis, C. Chourpiliadis, D. Bantouna, J.C. Jaume and R.D. Paparodis.ÌýÌýBiochemically Euthyroid Patients with Symptoms Attributable to Thyroid Disease, Have a High Prevalence of Abnormal Bone Density and Fractures.ÌýÌýThe Endocrine Society.ÌýÌýOrlando, FL 2017.Ìý
- M.S. Khan, J.B. Hao, F. Chaudhry, A. Tiwari, H. Sharma and J.C. Jaume.ÌýÌýResponse to IVIG Leads to Diagnosis of Stiff Person Syndrome in a Patient with Limbic Encephalitis and GAD65 Autoantibodies without Diabetes.ÌýÌýThe Endocrine Society.ÌýÌýOrlando, FL 2017.
- J. B. Hao, S. Imam, P. Dar, M. A. Alfonso-Jaume, N. Elnagar and J. C. Jaume.ÌýÌýExtreme Insulin Resistance from Insulin Antibodies (Not Insulin Receptor Antibodies) Successfully Treated with Combination Immunosuppressive Therapy.ÌýÌýDiabetes Care. 2017 Feb;40(2):e19-e20Ìý
- I.A. Hajam, P.A. Dar, S, Imam, J.C. Jaume JC and J.H. Lee.ÌýÌýBacterial flagellin-a potent immunomodulatory agent.ÌýÌýExp Mol Med. 2017 Sep 1;49(9):e373
- J. B. Hao, A. Renno, S. Imam, M. A. Alfonso-Jaume, N. Elnagar and J. C. Jaume.ÌýÌýDevelopment of Type 1 Diabetes after Cancer Immunotherapy.ÌýÌýEndocr Pract Epub 2017Ìý
- O. Oraibi, L.I. Wharry, A.A. Lynn, F. Chaudhry, J.C. Jaume, J.Y. Jun.ÌýÌýA Case of Adrenal Malignant Pheochromocytoma Combined with Primary Malignant Lymphoma.ÌýThe Endocrine Society.ÌýÌýChicago, IL 2018
- S. Imam, K.I. Almotah, P. Dar, A.S. AlKhudhair, R. Lamendella, J.C. Jaume.ÌýÌýProlonged Nursing (late Weaning), Delays The Onset Of Type 1 Diabetes In The Genetic Susceptible Humanized Mouse Model Of T1D.ÌýÌýThe Endocrine Society.ÌýÌýChicago, IL 2018
- C.P. Chourpiliadis, G. Antoniou, S. Kasikis, P-C.P. Koukoutsidi, L-N. Diamantopoulos, D. Bantouna, J.C. Jaume, R. Paparodis.ÌýÌýFractures of Any Kind, at Any Age Predict Low Bone Mineral Density and Osteoporosis.ÌýThe Endocrine Society.ÌýÌýChicago, IL 2018
- S. Alhassan, M. Rudoni, J.C. Jaume.ÌýÌýProlonged Glucosuria After Discontinuation Sglt2 Inhibitors: Implications For Weekly Dosing And Extended Risk Of Euglycemic Diabetes Keto-acidosis.ÌýÌýThe Endocrine Society.ÌýÌýChicago, IL 2018
- R. Paparodis, D. Bantouna, S. Imam, J.C. Jaume.ÌýThe Impact of Follicular Variant Papillary Thyroid Cancer (FV-PTC) in Features of Tumor Aggressiveness in Thyroid Papillary Microcarcinomas and Macrocarcinomas.ÌýÌýThe Endocrine Society.ÌýÌýChicago, IL 2018
- S. Kasikis, G. Antoniou, P-C. P. Koukoutsidi, C.P. Chourpiliadis, D. Bantouna, M. Panagiota, J.C. Jaume, R. Paparodis.ÌýÌýBone Mineral Density Abnormalities in Patients with Biochemically Euthyroid Thyroiditis.ÌýÌýThe Endocrine Society.ÌýÌýChicago, IL 2018
- A. Tiwari, H. Al-Robeh, H Sharma, Z. Ammari, M. Saud Khan, J. C. Jaume.ÌýÌýSteroid-induced diabetic ketoacidosis in patient with type 2 diabetes mellitus.ÌýEndocr Pract Epub 2018
- Ammari Z, Pak SC, Ruzieh M, Dasa O, Tiwari A, Jaume JC, Alfonso-Jaume MA.ÌýÌýPosttransplant Tacrolimus-Induced Diabetic Ketoacidosis: Review of the Literature.ÌýCase Rep Endocrinol. 2018 May 9;2018:4606491.
- Imam S, Dar P, Paparodis R, Almotah K, Al-Khudhair A, Hasan SA, Salim N, Jaume JC.Ìý Nature of coexisting thyroid autoimmune disease determines success or failure of tumor immunity in thyroid cancer. ÌýJ Immunother Cancer. 2019 Jan 7;7(1):3.
- Imam S, Prathibha R, Dar P, Almotah K, Al-Khudhair A, Hasan SA, Salim N, Jilani TN, Mirmira RG, Jaume JC.Ìý eIF5A inhibition influences T cell dynamics in the pancreatic microenvironment of the humanized mouse model of Type 1 Diabetes.Ìý Sci Rep. 2019 Feb 7;9(1):1533.
- Paparodis RD, Bantouna D, Imam S, Jaume JC.Ìý The non-interventional approach to papillary thyroid microcarcinomas. An "active surveillance" dilemma.Ìý Surg Oncol. 2019 Jun;29:113-117.
- Pappada SM, Owais MH, Cameron BD, Jaume JC, Mavarez-Martinez A, Tripathi RS, Papadimos TJ.Ìý An Artificial Neural Network-based Predictive Model to Support Optimization of Inpatient Glycemic Control.Ìý Diabetes Technol Ther. 2020 Feb 6. doi: 10.1089/dia.2019.0252. [Epub ahead of print].
- Paparodis RD, Karvounis E, Bantouna D, Chourpiliadis C, Chourpiliadi H, Livadas S, Imam S, Jaume JC.Ìý Incidentally Discovered Papillary Thyroid Microcarcinomas Are More Frequently Found in Patients with Chronic Lymphocytic Thyroiditis Than with Multinodular Goiter or Graves' Disease.Ìý Thyroid. 2020 Feb 20. doi: 10.1089/thy.2019.0347. [Epub ahead of print]
Book Chapters
- J.C. Jaume.ÌýÌýEndocrine autoimmunity.ÌýÌýIn Greenspan’s Basic & Clinical Endocrinology.ÌýÌý10th ed. Gardner DG and Shoback DM, Eds. McGraw-Hill Medical, 2017, Chapter 2; pages 29-48 (Last 6 editions).
- H. Chen, D.F. Schneider, H. Mazeh, J.C. Jaume, S. Lubner.ÌýÌýCancer of the Endocrine System.ÌýÌýIn Abeloff’s Clinical Oncology.ÌýÌý5th ed.ÌýAbeloff MD, Armitage JO, Niederhuber JE, Kastan MB and McKenna WG, Eds.ÌýÌýChurchill Livingstone Elsevier, 2013, Chapter 71, pagesÌý1112-1142.
- N. Elnagar, S. Alhassan, F. Khogeer, J. Jun, F. Chaudhry, M. Alfonso-Jaume, J.C. Jaume.ÌýÌýThe Noha (nəʊ ˈhaÊŠ) Manual of Inpatient Diabetes Management.ÌýÌýKindle Direct Publishing -Amazon.com, 2018.Ìý
Ìý Ìý Ìý ÌýÌý
Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý Ìý
ÌýFund # 2402325